During acute DSS colitis, the daily treatment of FDD mice with EcN-HldSE also significantly increased circulating GLP-1 (Fig. 5, A and B) and reduced weight loss and colon shortening (Fig. 5, C and D). This evidence concerns the gene GLP1R and colitis.